Opus Genetics, Inc. — 10-Q Filings
54 10-Q filings on record
This page lists all 10-Q filings submitted to the SEC by Opus Genetics, Inc. (IRD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Opus Genetics, Inc. has filed 54 10-Q documents with the SEC since 2003. To view all SEC filings by Opus Genetics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10KSB
10QSB
144
25
3
4
4/A
424A
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRE 14C
PREC14A
PRER14A
PRER14C
PRRN14A
PX14A6G
REGDEX
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001140361-25-041547 | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | 10-Q | 0001140361-25-030836 | Aug 13, 2025 | Jun 30, 2025 |
| 10-Q | 10-Q | 0001140361-25-019266 | May 15, 2025 | Mar 31, 2025 |
| 10-Q | 10-Q | 0001140361-24-046045 | Nov 12, 2024 | Sep 30, 2024 |
| 10-Q | 10-Q | 0001140361-24-037068 | Aug 13, 2024 | Jun 30, 2024 |
| 10-Q | 10-Q | 0001140361-24-025481 | May 10, 2024 | Mar 31, 2024 |
| 10-Q | 10-Q | 0001140361-23-052749 | Nov 13, 2023 | Sep 30, 2023 |
| 10-Q | 10-Q | 0001140361-23-039196 | Aug 11, 2023 | Jun 30, 2023 |
| 10-Q | 10-Q | 0001140361-23-024504 | May 15, 2023 | Mar 31, 2023 |
| 10-Q | 10-Q | 0001140361-22-040029 | Nov 4, 2022 | Sep 30, 2022 |
| 10-Q | 10-Q | 0001140361-22-029461 | Aug 12, 2022 | Jun 30, 2022 |
| 10-Q | 10-Q | 0001140361-22-019002 | May 13, 2022 | Mar 31, 2022 |
| 10-Q | 10-Q | 0001140361-21-037545 | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | 10-Q | 0001140361-21-028115 | Aug 12, 2021 | Jun 30, 2021 |
| 10-Q | 10-Q | 0001140361-21-016458 | May 7, 2021 | Mar 31, 2021 |
| 10-Q | 10-Q | 0001140361-20-024042 | Oct 29, 2020 | Sep 30, 2020 |
| 10-Q | 10-Q | 0001140361-20-018406 | Aug 14, 2020 | Jun 30, 2020 |
| 10-Q | 10-Q | 0001140361-20-010906 | May 7, 2020 | Mar 31, 2020 |
| 10-Q | 10-Q | 0001140361-19-019932 | Nov 6, 2019 | Sep 30, 2019 |
| 10-Q | 10-Q | 0001140361-19-014413 | Aug 7, 2019 | Jun 30, 2019 |
| 10-Q | 10-Q | 0001140361-19-008945 | May 10, 2019 | Mar 31, 2019 |
| 10-Q | 10-Q | 0001140361-18-042255 | Nov 2, 2018 | Sep 30, 2018 |
| 10-Q | 10-Q | 0001140361-18-035394 | Aug 3, 2018 | Jun 30, 2018 |
| 10-Q | 10-Q | 0001140361-18-021763 | May 4, 2018 | Mar 31, 2018 |
| 10-Q | 10-Q | 0001140361-17-040967 | Nov 3, 2017 | Sep 30, 2017 |
| 10-Q | 10-Q | 0001140361-17-030254 | Aug 4, 2017 | Jun 30, 2017 |
| 10-Q | 10-Q | 0001140361-17-018125 | May 3, 2017 | Mar 31, 2017 |
| 10-Q | REXAHN PHARMACEUTICALS, INC 10-Q 9-30-2016 | 0001140361-16-084902 | Nov 4, 2016 | Sep 30, 2016 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2016 | 0001140361-16-075030 | Aug 5, 2016 | Jun 30, 2016 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2016 | 0001140361-16-063841 | May 6, 2016 | Mar 31, 2016 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2015 | 0001140361-15-039272 | Nov 2, 2015 | Sep 30, 2015 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2015 | 0001140361-15-030473 | Aug 7, 2015 | Jun 30, 2015 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2015 | 0001140361-15-018528 | May 8, 2015 | Mar 31, 2015 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2014 | 0001140361-14-041326 | Nov 12, 2014 | Sep 30, 2014 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2014 | 0001140361-14-032243 | Aug 13, 2014 | Jun 30, 2014 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2014 | 0001140361-14-020971 | May 14, 2014 | Mar 31, 2014 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2013 | 0001140361-13-042173 | Nov 13, 2013 | Sep 30, 2013 |
| 10-Q | REXAHN PHARMACEUTICALS INC 10-Q 6-30-2013 | 0001140361-13-031714 | Aug 12, 2013 | Jun 30, 2013 |
| 10-Q | REXAHN PHARMACEUTICALS, INC 10-Q 3-31-2013 | 0001140361-13-019748 | May 9, 2013 | Mar 31, 2013 |
| 10-Q | REXAHN PHARMACEUTICALS, INC 10-Q 9-30-2012 | 0001140361-12-046272 | Nov 8, 2012 | Sep 30, 2012 |
| 10-Q | REXAHN PHARMACEUTICALS, INC 10-Q 6-30-2012 | 0001140361-12-035725 | Aug 8, 2012 | Jun 30, 2012 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 03-31-2012 | 0001140361-12-023967 | May 9, 2012 | Mar 31, 2012 |
| 10-Q | REXAHN PHARMACEUTICALS 10-Q 9-30-2011 | 0001140361-11-052700 | Nov 9, 2011 | Sep 30, 2011 |
| 10-Q | REXAHN PHARMACEUTICALS INC 10-Q 6-30-2011 | 0001140361-11-040635 | Aug 9, 2011 | Jun 30, 2011 |
| 10-Q | REXAHN PHARMACEUTICALS 10-Q 3-31-2011 | 0001140361-11-026016 | May 9, 2011 | Mar 31, 2011 |
| 10-Q | REXAHN PHARMACEUTICALS 10-Q 9-30-2010 | 0001140361-10-045796 | Nov 15, 2010 | Sep 30, 2010 |
| 10-Q | REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2010 | 0001140361-10-033716 | Aug 16, 2010 | Jun 30, 2010 |
| 10-Q | REXAHN PHARMACEUTICALS INC 10-Q 3-31-2010 | 0001140361-10-022639 | May 21, 2010 | Mar 31, 2010 |
| 10-Q | REXAHN PHARMACEUTICALS 10-Q 9-30-2009 | 0001140361-09-026314 | Nov 16, 2009 | Sep 30, 2009 |
| 10-Q | REXAHN PHARMACEUTICALS 10-Q 6-30-2009 | 0001140361-09-018473 | Aug 10, 2009 | Jun 30, 2009 |